Management Credibility Analysis
Upcoming Catalysts
Verified event feedCompany profile
No description available
- Chief executive
- Not disclosed
- Headquarters
- 50 NORTHERN AVENUE, BOSTON, MA
- Founded
- Not disclosed
📈 Company Timeline
Vertex Pharmaceuticals Incorporated reported A director or senior management change or compensation event
Vertex Pharmaceuticals Incorporated filed an 8-K covering a director or senior management change or compensation event.
Vertex Pharmaceuticals Incorporated reported A director or senior management change or compensation event
Vertex Pharmaceuticals Incorporated filed an 8-K covering a director or senior management change or compensation event.
Vertex Pharmaceuticals Incorporated filed Form 10-Q
Vertex Pharmaceuticals Incorporated submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
Vertex Pharmaceuticals Incorporated reported Operating or financial results
Vertex Pharmaceuticals Incorporated filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
Vertex Pharmaceuticals Incorporated reported A material agreement
Vertex Pharmaceuticals Incorporated filed an 8-K covering a material agreement, Regulation FD disclosure, another company event, supporting financial statements or exhibits.
Capital Structure & Financial Position
Financial strength and liquidity analysisPeer Comparison - Health Care
| Company | Price | Market Cap |
|---|---|---|
| LLY - Eli Lilly and Company |
$1,276.13
Yahoo Finance |
$1.20T |
| JNJ - Johnson & Johnson |
$256.74
Yahoo Finance |
$618.71B |
| ABBV - AbbVie Inc. |
$284.80
Yahoo Finance |
$503.28B |
| UNH - UnitedHealth Group Incorporated |
$418.43
Yahoo Finance |
$375.58B |
| MRK - Merck & Co., Inc. |
$148.55
Yahoo Finance |
$366.50B |